Britt Meelby Jensen

From 2019 to. Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made good.

Category Britt Meelby Jensen Wikimedia Commons

Bestyrelsesmedlem Britt Meelby Jensen overtager.

. Britt Meelby Jensen has served as board member of The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO. Britt Meelby Jensen is on the board of Novo Holdings An and 6 other companies. After this interview in December 2018 Britt Meelby Jensen left Zealand Pharma to become the new CEO of Atos Medical.

From 2015 to 2019 Britt Meelby Jensen was CEO of Zealand Pharma. On March 1 2022 the former Zealand Pharma CEO steps back from the position in Atos Medical which Coloplast acquired for EUR 22bn in November. 1 day agoBritt Meelby Jensen is the new CEO of Ambu Photo via Atos Medical Ambu today said it has hired Board Member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez effective tomorrow.

Britt Meelby Jensen synes godt om dette. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed. I am very pleased to welcome Britt to the Novo Holdings Board of Directors said Lars Rebien Sørensen Chairman of the Boards of Novo Holdings and the Novo Nordisk Foundation.

Britt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry. The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer. His place at the helm will be taken over by Britt Meelby Jensen who has been a board member of Ambu since 2019 a position she leaves as part of the executive reshuffle.

For example the establishment of a permanent Life Science office referring to the Danish Minister for Industry Business and Financial Affairs is a step in the right direction says Meelby Jensen. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the. AF STEFAN NYGAARD HANSEN.

Britt has over twenty years of experience from the life science industry pharma diagnostics biotech and medtech. Britt Meelby Jensen har senest været administrerende direktør for Swedish Atos Medical der senere blev solgt til til Coloplast. Past and present positions of Britt Meelby Jensen.

At Atos Medical we are also devoted to voice. Britt Meelby Jensen will be continuing in her role in the Novo Advisory Group where she has served since 2020. Ambus topchef Juan Jose Gonzales stopper i det ombruste selskab efter tre år på posten.

List of companies where Britt Meelby Jensen holds appointments. 1 day agoBritt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed.

International Marketing Management Copenhagen Business School 2000 MBA Economics Solvay Business. Competencies and special tasks on the Board. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale.

Jensen previously was Chief Executive Officer at Zealand Pharma A Chief Executive Officer at Atos Medical AB Vice President General Manager at Dako Denmark ApS and Chief Executive Officer for. Britt is a highly competent and experienced life. Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made.

Press Releases One News Page. Opdateres Juan Jose Gonzales stopper i Ambu i morgen. View Britt Meelby Jensens professional profile on Relationship Science the database of decision makers.

Britt Meelby Jensen Address Related People and Companies. 1 day ago From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until the sale of the company to Coloplast in early 2022 From 2015 to 2019 Britt Meelby Jensen served as CEO of Zealand. Britt Meelby Jensen is a Danish citizen.

She holds a MSc in International Marketing and Management from Copenhagen Business School and has earned an MBA from Solvay Business School Université Libre de Bruxelles. Britt Meelby Jensen is Vice President at Agilent Technologies Inc. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale of the company to Coloplast in early 2022.

1 day agoEffective tomorrow May 20 Juan Jose Gonzalez will no longer be the chief executive of Danish medtech firm Ambu the firm has announced in a press release. Today is World Voice Day an annual event dedicated to the celebration of the phenomenon of voice. Ambu-chef stopper - Britt Meelby Jensen overtager.

Den verden Danmark vender tilbage til efter Covid-19 er en radikalt. The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO. Fra 2015-2019 var Britt Meelby Jensen administrerende direktør for det børsnoterede biotekselskab Zealand Pharma og hun har tidligere også stået i spidsen for Dako og har haft ledende stillinger i Novo Nordisk.

The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO. Britt Meelby Jensen Company Director Profile. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the.

After three years at the front of Swedish medtech company Atos Medical Britt Meelby Jensen has set the date for when she will leave the company a press release announces.

Britt Meelby Jensen Crunchbase Person Profile